Loading tape…Loading tape…
VEEV
VEEV
VEEV
Veeva Systems has announced that Veeva DQS cleans data for more than 1 million subjects across over 1,000 studies. This operational milestone aligns with the company's full-year revenue of approximately $3.20 billion and a market capitalization of $44.69 billion. Currently, Veeva trades at a PE ratio of 44.30, backed by a TTM EPS of 6.25 and a free cash flow yield of 3.68%.
Based on prnewswire.comIs Veeva (VEEV) a Buy as Wall Street Analysts Look Optimistic?
Veeva Systems Inc. (VEEV) is Attracting Investor Attention: Here is What You Should Know
Veeva to Host Virtual Investor Day on November 5, 2026
VEEV Expands IQVIA Partnership With Clinical Operations Software Suite
Veeva Systems (VEEV) Increases Despite Market Slip: Here's What You Need to Know
IQVIA opte pour les applications de Veeva Clinical Operations
Revenue & Net Income (5Y)
EPS & Growth (5Y)
Free Cash Flow (5Y)
Capital Returns
Operating & Net Margin (5Y)
CapEx vs. Free Cash Flow (5Y)
Capital Allocation (5Y)
R&D and SG&A Intensity (5Y)
EBITDA (5Y)
Cost of Revenue (5Y)
Market Cap (5Y)
Ask Blinx with professional market data, charts beside chat, and your portfolio context.
Default quotes are Lang & Schwarz. NASDAQ is the delayed listing price. Charts stay daily. Not investment advice.